Raysearch Laboratories
157,4 SEK -1,87%5 investorer følger denne virksomhed
RaySearch Laboratories is a biotechnology company. The company specializes in the development of software solutions for the healthcare industry. An area where the company's products are used is in the treatment of cancer and other serious diseases. The company's products include products for dose planning and information systems. Various features include machine learning, computational speed, automated planning, virtual simulation, adaptive therapy, and digital workflows. The products are used by several clinics around the global market.
Læs mereOmsætning
1,02 mia.
EBIT %
11,24 %
P/E
66,13
Udbytteafkast, %
1,27 %
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
RAY B
Daglig lav / høj pris
157 / 162,8
SEK
Markedsværdi
5,4 mia. SEK
Aktieomsætning
3,34 mio. SEK
Volumen
21 t
Finanskalender
Delårsrapport
08.11.2024
Årsrapport
21.02.2025
Delårsrapport
09.05.2025
Generalforsamling
22.05.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Johan Löf | 16,5 % | 53,0 % |
Northern Trust Company, London Branch | 8,1 % | 2,7 % |
The bank of New York Mellon SA/NV. W8IMY | 6,3 % | 2,1 % |
BNP Paribas SA Paris, W8IMY (GC) | 5,6 % | 1,9 % |
Swedbank Robur Fonder AB | 5,3 % | 1,7 % |
Anders Brahme | 3,8 % | 11,3 % |
Second AP Fund | 3,6 % | 1,2 % |
JP Morgan Chase Bank Na, W9 | 3,5 % | 1,2 % |
Carl Filip Bergendal | 3,4 % | 10,0 % |
Caceis Bank, W8Imy | 3,3 % | 1,1 % |
ViserAlle indholdstyper
RaySearch Laboratories: Invitation to presentation of RaySearch's interim report for the third quarter of 2024
RaySearch Laboratories: Another three centers under the French Unicancer framework select RayStation
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools